甲状腺相关眼病合并眼压升高的临床研究  

Clinic analysis of ocular hypertension in thyroid-associated ophthalmopathy

作　　者：刘芳 王向华[2] 

机构地区：[1]河南驻马店市中心医院眼科,463000 [2]河南省郑州市中心医院眼科,450000

出　　处：《中国医疗前沿》2011年第3期63-64,共2页China Healthcare Innovation

基　　金：河南省2008年科技攻关项目(编号:082102310049)

摘　　要：目的探讨甲状腺相关眼病(thyroid-associated ophthalmopathy,TAO)合并眼压升高的相关影响因素。方法对2007年1月～2009年12月诊治的97例(171眼)TAO患者的临床资料进行分析,并根据眼压是否升高,将患者进行分组比较。结果与正常眼压组比较,高眼压组的TAO患者年龄偏大,无性别差异,均伴有眶压的升高,突眼的程度也较重。大部分患者通过治疗TAO,眼压可恢复正常。结论 TAO患者的眼压升高有其独特的临床特点,积极的TAO治疗可以有效地控制眼压。Objective To analyze the influencing factors of thyroid-associated ophthalmopathy（TAO） with ocular hypertension.Methods The clinical data of 97 patients（171 eyes） with TAO from January 2007 to December 2009 in our Hospital was retrospectively analyzed,and the patients were groups compared according to the intraocular pressure.Results Compared with normal intraocular pressure group,the patients in high intraocular pressure group were older,more serious exophthalmos,with no gender differences and increased orbital pressure.The intraocular pressure of most patients could return to normal with treatment TAO.Conclusions Specific clinical features was found in TAO patients with ocular hypertension.The intraocular pressure in most case can be controlled by effective treatment of TAO.

关 键 词：甲状腺相关眼病 眼压 临床特征 

分 类 号：R777.5[医药卫生—眼科]